Abbott Lingo Review 2026: Price, Glucose Accuracy, HSA/FSA Status

Abbott’s Lingo puts a continuous glucose sensor in the hands of people without diabetes, no prescription needed. The first independent study of Lingo itself shows it follows glucose trends well, but its exact numbers, its arrows and its readings after a sugary meal deserve more caution than the app’s smooth curves suggest.

Presented By Our Partners

Abbott entered the US consumer biowearables market with Lingo and Libre Rio (Abbott Newsroom) after MassDevice reported that Abbott won FDA clearance for Lingo as an over-the-counter glucose monitor (MassDevice). Wareable reported the US launch starting at $49 (Wareable), and Close Concerns reported that Lingo’s Walmart launch marked the first brick-and-mortar availability of an over-the-counter CGM in the US (Close Concerns). This review looks past the marketing to what studies show Lingo and its Libre sensor family actually measure.

What Is Abbott Lingo?

Abbott Lingo is an over-the-counter continuous glucose monitor, sold without a prescription to people without diabetes, that reads glucose under the skin every few minutes and sends the data to a smartphone app.

Lingo comes from Abbott’s diabetes business. In the first independent study of the device, the Lingo Glucose Biosensor, made by Abbott Diabetes Care, recorded glucose every 5 minutes and displayed values between 55 and 200 mg/dL; readings outside that range showed as the nearest limit (PMID 42764665). Those authors note that Lingo gained FDA clearance through substantial equivalence with Abbott’s FreeStyle Libre 2, so Libre 2 data are a reasonable guide to its performance, though manufacturing differences may exist.

Coverage has tracked Lingo’s spread more than its accuracy. Engadget reported that Abbott’s over-the-counter glucose monitor became available in the US (Engadget), Fierce Biotech said the over-the-counter CGM market grew with Lingo’s debut (Fierce Biotech), and Drug Delivery Business reported an Amazon retail deal (Drug Delivery Business). Athletech News published a first-person trial (Athletech News). These details come from headlines and were not tested by Healthcare Discovery.

How Does Abbott Lingo Work?

A thin filament under the skin measures glucose in the fluid between cells, called interstitial fluid, and the sensor sends readings to your phone. Because glucose reaches that fluid a few minutes after it reaches the blood, the sensor runs slightly behind a fingerstick, especially when glucose is rising or falling fast.

In the Lingo study, the sensor lagged a fingerstick meter by about 6.2 minutes on average, and shifting its readings by 5 minutes improved agreement (PMID 42764665). In a separate study of the Libre 2 in healthy men, the sensor read consistently lower than fingerstick blood during a glucose tolerance test (PMID 39275680).

The app turns those readings into curves and trend arrows. The curve is the most trustworthy part. The arrow, which predicts where glucose is heading right now, is the least.

How Accurate Is Abbott Lingo? What the Research Shows

In the one independent study of Lingo itself, readings differed from a fingerstick meter by 12.9 percent on average and fell within 15 percent or 15 mg/dL only two thirds of the time, with bigger errors after sugar and at higher glucose. Studies of the Libre 2 that Lingo was cleared against show the same pattern in healthy people: good trends, rougher single values.

Lingo in adults without diabetes. A Yale and University of South Florida team tested Lingo in 39 adults aged 18 to 28 without diabetes, across rest, moderate exercise, a sugar-sweetened drink and a placebo drink. The mean absolute relative difference (MARD) from a fingerstick meter was 12.9 percent, readings ran 4.8 mg/dL low on average, and 66.5 percent fell within 15 percent or 15 mg/dL. Agreement was worse after the sugar drink than the placebo (MARD 15.3 versus 10.6 percent), worse when glucose changed quickly, and 13.8 percent of trend arrows fell in moderate to extreme risk zones. Exercise had no consistent effect. The authors concluded that Lingo agreed with overall glucose trends but was less reliable for exact values, and cautioned against using it for diagnostic thresholds or real-time arrows (PMID 42764665). In the full text, error grew above about 99 mg/dL, and the sensor read low in 30 of the 39 participants.

The Libre 2 in people with diabetes. In Abbott’s pivotal study of the FreeStyle Libre 2 against a laboratory reference in 144 adults and 129 children with diabetes, MARD was 9.2 percent in adults and 9.7 percent in children, and 93.2 and 92.1 percent of readings fell within 20 percent or 20 mg/dL (PMID 32954812). That study used a lab analyzer, a stricter reference than a fingerstick meter, and people with diabetes, whose glucose spans a much wider range.

The Libre 2 in healthy people. In 44 healthy young men given a glucose tolerance test, the Libre 2’s MARD was 12.9 percent and it under-read capillary blood at every time point, for example 144.3 versus 159.9 mg/dL at 30 minutes (PMID 39275680). In 13 recreational runners, MARD during steady treadmill running was 13.8 percent on the arm and 11.4 percent on the chest, only about half of readings were within 10 percent, and the authors concluded the sensor was not valid for single-point readings but was valid for trends (PMID 39251197).

What normal looks like. A multicenter study fitted 153 healthy people without diabetes, aged 7 to 80, with a Dexcom G6 sensor. They spent a median 96 percent of the day between 70 and 140 mg/dL, about 30 minutes a day above 140 and about 15 minutes below 70 (PMID 31127824). Brief rises after meals are normal, so a single spike on Lingo is not a warning sign.

Health outcomes. We found no peer-reviewed study on PubMed, as of October 28, 2026, showing that people without diabetes who use Lingo lose weight, lower their diabetes risk or improve other health outcomes.

Company ties: three of the Libre 2 pivotal study authors shown in PubMed list Abbott Diabetes Care, the maker of the Libre 2 and Lingo (PMID 32954812). The Lingo study lists Yale, University of South Florida and Columbia affiliations only, and the other studies list university, hospital or research center affiliations only. PubMed affiliations are not a full disclosure of funding or conflicts.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

What Abbott Lingo Gets Right

Lingo makes continuous glucose data easy to get without a prescription, and its trends track real changes well enough to show how your body responds to meals and activity. It is also one of the few consumer health sensors with an independent study of the device itself.

Trends you can learn from. In the Lingo study, nearly all readings fell in clinically acceptable zones and overall curves followed fingerstick trends, which is what matters for spotting patterns across days (PMID 42764665).

A proven sensor family. Lingo was cleared against the Libre 2, whose accuracy in people with diabetes is well documented (PMID 32954812).

Easy to buy. Lingo is sold without a prescription online and, per Close Concerns and eMarketer, in Walmart stores (eMarketer).

Where Abbott Lingo Falls Short

The weaknesses are exact values that can be off by more than 15 percent a third of the time, bigger errors right after eating sugar, unreliable trend arrows, a display that stops at 55 and 200 mg/dL, and no evidence that wearing it improves health.

Single numbers are rough. Only 66.5 percent of Lingo readings fell within 15 percent or 15 mg/dL of a fingerstick, and errors grew after a sugar drink and at higher glucose (PMID 42764665). Do not judge a meal by one peak reading.

Arrows can mislead. 13.8 percent of trend arrows fell in moderate to extreme risk zones (PMID 42764665), so do not use them to decide whether to eat or exercise in the moment.

Not a diabetes test. Sensors in this family read lower than blood during a glucose tolerance test (PMID 39275680), and the Lingo authors warn against self-screening for diabetes or hypoglycemia with it. Diabetes is diagnosed with lab tests such as an A1C or fasting glucose.

Evidence of benefit is missing. Watching your glucose can be interesting, but no study we found shows that it changes long-term health in people without diabetes.

Abbott Lingo vs Dexcom Stelo vs FreeStyle Libre 2

Lingo and Dexcom’s Stelo are the two main over-the-counter glucose sensors in the US; the FreeStyle Libre 2 is the diabetes sensor Lingo was cleared against. Lingo has an independent accuracy study of the device itself in people without diabetes; we did not verify one for Stelo.

The Stelo row draws on the 2026 Lingo study, which describes Lingo and Stelo as the over-the-counter sensors authorized for people without diabetes and cites Dexcom’s report of more than 15,000 Stelo users without diabetes and more than 12,000 with prediabetes (PMID 42764665). Dexcom announced Stelo’s availability as the first over-the-counter glucose biosensor in the US (01net), and TipRanks reported Piper Sandler saying its cost came in a bit higher than expected (TipRanks).

For Abbott’s sensor that tracks ketones as well as glucose, see our Abbott Libre Duo explainer. If you want sleep, heart and activity data to sit beside your glucose curves, compare our Oura Ring 5 price and blood pressure guide and our Apple Watch Series 12 review. For the bigger picture of what drives cardiometabolic risk, see our heart health evidence review. Every device we track is in our healthtech wearables guide.

How Much Does Abbott Lingo Cost, and Is It HSA or FSA Eligible?

Lingo launched in the US starting at $49, according to Wareable (Wareable). We could not confirm its current price, plan options or any recent price change as of October 28, 2026, so check Abbott’s Lingo site or retailers before you buy. We found no confirmation that Lingo is HSA or FSA eligible as a standard purchase, and insurance does not cover it as far as we found.

Some plans may accept a glucose sensor with a letter of medical necessity from your clinician, so ask your HSA or FSA administrator before assuming it qualifies. Remember that sensors are replaced on a schedule, so the real cost is ongoing rather than one time.

Who Should Buy Abbott Lingo, and Who Should Skip It?

Lingo suits adults without diabetes who want to understand how their own meals, sleep and exercise affect glucose, and who will use trends rather than single readings. It is a poor fit for people with diabetes, for anyone trying to diagnose themselves, and for people prone to food anxiety.

Good candidates:

• Adults without diabetes who want short-term feedback on how different meals and activities affect their glucose.
• People with risk factors for type 2 diabetes who are already working with a clinician and want extra motivation for diet and exercise changes.
• Recreational athletes curious about glucose trends around training, accepting that single readings during exercise are rough.

Better served by something else:

• Confusion, fainting or a seizure in someone who may have very low blood sugar is an emergency. Call 911; do not wait for a sensor reading.
• People with diabetes, especially those using insulin: talk to your clinician about a prescription CGM made for diabetes care.
• Anyone with symptoms such as extreme thirst, frequent urination or unexplained weight loss: get a lab test such as an A1C rather than relying on Lingo.
• People with a history of disordered eating, for whom constant feedback on every meal may do more harm than good.

If your readings or symptoms send you looking for an endocrinologist or primary care doctor, the Healthcare Discovery doctor directory lists clinicians by state and specialty.

What This Means for You

Lingo is one of the rare consumer health sensors with an independent study of the device itself, and that study gives a clear answer: it follows your glucose trends well but its single numbers, its arrows and its readings right after sugar are rough. That makes it a learning tool, not a medical test.

If you buy it, use a sensor or two to learn your patterns, look at the shape of your curves over several days, and remember that rises after meals are normal. If anything worries you, confirm it with a lab test and a clinician rather than another sensor.

Compiled by Healthcare Discovery from the cited PubMed studies and Abbott’s launch materials. Every PMID, study size and result on this page was checked against PubMed on October 28, 2026. Launch, price, specification and review details come from the named publications’ headlines and listings and were not independently tested. No Healthcare Discovery hands-on testing was done.

Sources

1. Prakash N, et al. Agreement of over-the-counter continuous glucose monitors with capillary-meter glucose in young adults without diabetes. Journal of Diabetes Science and Technology, 2026. PMID 42764665
2. Alva S, et al. Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes. Journal of Diabetes Science and Technology, 2020. PMID 32954812
3. Fellinger E, et al. Analytical performance of the FreeStyle Libre 2 glucose sensor in healthy male adults. Sensors, 2024. PMID 39275680
4. Mason LJ, et al. Validating the use of continuous glucose monitors with nondiabetic recreational runners. International Journal of Sports Physiology and Performance, 2024. PMID 39251197
5. Shah VN, et al. Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study. Journal of Clinical Endocrinology and Metabolism, 2019. PMID 31127824
6. Abbott. Abbott enters U.S. consumer biowearables market with Lingo and Libre Rio. Abbott Newsroom
7. MassDevice. Abbott wins FDA clearance for its Lingo OTC glucose monitor. MassDevice
8. MedTech Dive. Abbott Lingo FDA clearance for over-the-counter CGM. MedTech Dive
9. Wareable. Abbott launches its Lingo biowearable in the US, starts at $49. Wareable
10. Engadget. Abbott’s OTC glucose monitor is now available in the US. Engadget
11. Fierce Biotech. Over-the-counter CGM market grows, with Abbott’s Lingo debut. Fierce Biotech
12. Close Concerns. Abbott’s Lingo launches at Walmart, marking first brick-and-mortar OTC CGM availability in the US. Close Concerns
13. eMarketer. Walmart lands first in-store retail deal for Abbott blood sugar monitoring device. eMarketer
14. Drug Delivery Business. Abbott inks Lingo retail deal with Amazon. Drug Delivery Business
15. Athletech News. I tried Abbott Lingo continuous glucose monitor: CGM review. Athletech News
16. 01net. Stelo by Dexcom, the first over-the-counter glucose biosensor in the U.S., is now available. 01net
17. TipRanks. Dexcom’s Stelo cost came in a bit higher than expected, says Piper Sandler. TipRanks

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.

Keep Reading on Healthcare Discovery

• The Finnish Heat Prescription: Sauna, Heat Shock Proteins, and the 2026 Science of Hormetic Longevity
• The Daily Rounds: Longevity & Health Care Brief | April 10, 2026
• The Gut as a Longevity Organ: 2026 Microbiome Research Reshaping Aging Medicine